So when my urologist said in 2019 that my PSA test showed the most aggressive form of prostate cancer, I was not prepared. I was 68, and my annual tests had always been normal. Soon I embarked on a ...

When we use androgen deprivation therapy, we are lowering testosterone levels typically by turning off the testes from making testosterone. This starves cancer cells, causing them to shut down, ...

Androgen deprivation therapy is a lifesaving therapy used by thousands of men each year, but some patients are warning of serious mental health risks.

A recent trial reveals metformin does not enhance survival in metastatic prostate cancer but offers significant metabolic ...

Androgen deprivation therapy is commonly used to treat prostate cancer, often on an open-ended basis for therapy of advanced prostate cancer. It is estimated that 44 percent of men with prostate ...

I am Sandy Srinivas and I'm the host of the Medscape InDiscussion podcast series on prostate cancer. Today we want to talk about bone health and survivorship with androgen deprivation therapy (ADT).

For decades, clinicians were uncertain as to whether the addition of prostate radiotherapy (RT) to systemic androgen-deprivation therapy (ADT) improved survival for patients with locally advanced ...

Hormone therapy for prostate cancer is aimed at reducing or eliminating the amount of testosterone in your body to slow or stop prostate cancer cells from growing and multiplying. Hormone therapy ...

Therapeutic Rationale Androgens can drive prostate cancer growth, thus providing the rationale for using deprivation of androgens as a first line of treatment for prostate cancer. Unfortunately ...

Androgen deprivation therapy (ADT) for prostate cancer is associated with decreased bone mineral density (BMD) in patients. This decreased BMD can lead to an increased risk of fractures and ...

Androgen deprivation therapy is a proven treatment for prostate cancer, but it can trigger biochemical events that might cause the cancer to progress to androgen-independent disease. This Review ...

Androgen-deprivation therapy (ADT) is the first line of treatment for disseminated prostate cancer (PCa) and is also used as neoadjuvant and adjuvant therapy in conjunction with radiotherapy for ...